HealthQuill Obesity
Obesity is a health risk that needs to be tackled worldwide
Drugs Health Pharma

Novo Nordisk unveils new drug to fight obesity, says 13% effective

HQ Team March 11, 2024: Danish drugmaker Novo Nordisk’s oral medicine, amycretin, for obesity can cause up to 13% weight loss, the company.

Read More
Diabetes drugs used in weight-loss therapies may come with a risk of stomach paralysis, pancreatitis and bowel obstruction, a study by the University of British Columbia found.
Drugs Health Medical

Study finds unexpected link between weight loss and cancer risk

HQ Team March 4, 2024: Obesity is widely recognized as a risk factor for cancer, and a recent study sheds light on an.

Read More
More than one billion people worldwide are living with obesity and the disease has quadrupled among children and adolescents between five and 19 years of age, according to the World Health Organization.
Drugs Health Pharma

One billion people globally are suffering from obesity, says  WHO

HQ Team March 1, 2024: More than one billion people worldwide are living with obesity and the disease has quadrupled among children and.

Read More
Food crisis
Drugs Health Medical

Unveiling the impact of fasting diets on eating behaviors, sleep, and mood

HQ Team January 29, 2024: Fasting diets (FDs) have gained popularity for their impact on health, disease, and weight control. Despite the vast.

Read More
The FDA has seized “thousands of units” of counterfeit weight-loss injection Ozempic which have no information about the drug’s identity, quality or safety.
Drugs Health Pharma

FDA starts crackdown against fake Ozempic weight-loss drug 

HQ Team December 22, 2023: The FDA has seized “thousands of units” of counterfeit weight-loss injection Ozempic which have no information about the.

Read More
— at a time when President Emmanuel Macron is taking steps to stem the country’s industrial decline.
Drugs Health Pharma

Novo Nordisk invests $2.3b in France for diabetes, obesity drugs

HQ Team November 23, 2023: Novo Nordisk will invest $2.3 billion to expand production of its weight-loss and diabetes drug in Chartes, France..

Read More
Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5 billion plant in Germany to make devices for treating diabetes and obesity.
Drugs Health Pharma

Lilly to build $2.5b plant in Germany to make diabetes, obesity devices

HQ Team November 18, 2023: Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5.

Read More
Obesity
Drugs Health Medical

Role of fructose in obesity, a new perspective

HQ Team October 20, 2023: A new research paper suggests that fructose, a type of sugar, maybe a significant driver of obesity. While.

Read More
A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the University of Florida
Drugs Health Pharma

Weight-loss drug mimicking exercise may help treat obesity, diabetes

HQ Team October 2, 2023: A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the.

Read More
Semaglutide based weightloss drugs tied to increased suicide risk in a new study
Drugs Health Pharma

Novo Nordisk’s weight-loss drug Wegovy enters the UK market 

HQ Team September 4, 2023: Novo Nordisk, a Danish drugmaker, announced its weight-loss medicine, Wegovy, will be available in the UK in a.

Read More